Chemical Component Summary

Name(2S)-2-hydroxy-3-methyl-N-[(2S)-1-[[(5S)-3-methyl-4-oxo-2,5-dihydro-1H-3-benzazepin-5-yl]amino]-1-oxopropan-2-yl]butanamide
Identifiers(2~{S})-3-methyl-~{N}-[(2~{S})-1-[(3-methyl-4-oxidanylidene-2,5-dihydro-1~{H}-3-benzazepin-5-yl)amino]-1-oxidanylidene-propan-2-yl]-2-oxidanyl-butanamide
FormulaC19 H27 N3 O4
Molecular Weight361.435
TypeNON-POLYMER
Isomeric SMILESC[C@@H](C(=O)NC1c2ccccc2CCN(C1=O)C)NC(=O)[C@H](C(C)C)O
InChIInChI=1S/C19H27N3O4/c1-11(2)16(23)18(25)20-12(3)17(24)21-15-14-8-6-5-7-13(14)9-10-22(4)19(15)26/h5-8,11-12,15-16,23H,9-10H2,1-4H3,(H,20,25)(H,21,24)/t12-,15-,16-/m0/s1
InChIKeyPKXWXXPNHIWQHW-RCBQFDQVSA-N

Chemical Details

Formal Charge0
Atom Count53
Chiral Atom Count3
Bond Count54
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB12463 
NameSemagacestat
Groups investigational
DescriptionSemagacestat has been used in trials studying the treatment of Alzheimer Disease.
SynonymsSemagacestat
Categories
  • Amino Acids
  • Amino Acids, Peptides, and Proteins
  • Amyloid Precursor Protein Secretases, antagonists & inhibitors
  • Enzyme Inhibitors
  • Gamma Secretase Inhibitors and Modulators
CAS number425386-60-3

Related Resource References

Resource NameReference
PubChem 9843750
ChEMBL CHEMBL520733
ChEBI CHEBI:131158